BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190322
DTSTAMP:20190307T224853Z
CREATED:20181223T202727Z
LAST-MODIFIED:20190307T224853Z
UID:20529-1552867200-1553212799@globalbiodefense.com
SUMMARY:NHPC 2019 - National HIV Prevention Conference
DESCRIPTION:The 2019 National HIV Prevention Conference (NHPC) will be held March 18–21\, 2019 in Atlanta\, Georgia. \nThe National HIV Prevention Conference allows in-person collaboration between researchers and program personnel working in HIV prevention. The conference will bring together more than 3\,000 attendees committed to help refine\, improve and strengthen national and local response to HIV. \nThe theme for NHPC 2019 is “Getting to No New HIV Infections\,” which will highlight dynamic approaches to HIV prevention\, detection and management\, and the critical roles that different communities have in achieving this vision. \nThis four-day conference will include plenary sessions along with oral and poster presentations that highlight new HIV science and program activities. \nPlease visit the following links to register to attend the conference\, register to exhibit at the conference\, request space for the CBO/NGO Village\, and request space for an ancillary meeting. \nPlease visit the NHPC website for updates and conference information.
URL:https://globalbiodefense.com/event/nhpc-2019-national-hiv-prevention-conference/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/12/national-hiv-conference-2019-cdc.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20190307T225112Z
CREATED:20181223T215408Z
LAST-MODIFIED:20190307T225112Z
UID:20616-1552867200-1553039999@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs 2019
DESCRIPTION:SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March\, 2019 in London\, UK. \nThis year’s event will gather leaders from pharmaceutical companies\, academia and the wider scientific community together with regulatory agencies and public-private partnerships\, to discuss the growing threat of antibiotic resistance. \nHighlighted session topics and focus areas include: \n\nDevelopment of a pipeline of lysins for infections caused by multidrug-resistant gram-negative bacteria\nAnti-infective research: funding\, filing and finance\nDeveloping target product profiles for priority pathogens\nHow to mobilize private investors for antibiotic drug development\nWellcome Trust: funding opportunities for anti-infective research\nConsiderations for beta-lactams paired with beta-lactamase inhibitors\nA unique combination antibiotic therapy at Helperby\nRidinilazole for the treatment of C. difficile\nDeveloping new therapies for fungal infection\nPharmacodynamics to accelerate antimicrobial drug development for AMR\nOpportunities and challenges involved in pre-clinical development of novel immunotherapies\nEvaluations in prophylaxis and treatment murine models of pneumocystis pneumonia\n\nTo register visit www.superbugssuperdrugs.com/globalbiodefence \nGlobal Biodefense in an official media partner of Superbugs & Superdrugs 2019.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/superbugs-2019-london.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190315
DTEND;VALUE=DATE:20190317
DTSTAMP:20220906T195421Z
CREATED:20190212T015237Z
LAST-MODIFIED:20220906T195421Z
UID:23485-1552608000-1552780799@globalbiodefense.com
SUMMARY:Mass Gathering Medicine Summit 2019
DESCRIPTION:The fourth annual Mass Gathering Medicine Summit 2019 will be held 15-16 March 2019 in Las Vegas\, Nevada. \nThis annual conference & symposium gathers stakeholders and experts from specialty groups\, hospitals\, major sporting events\, corporate sponsors and music festivals. \nHighlighted sessions include: \n\nDrug Checking: Bridging Public Health and Consumer Safety to Reduce Drug-Related Health Risks at Music Festivals\nPanel: Who “Owns” Event Medicine\nFive Things a Pharmacist Wish You Knew about Event Medicine\nNCState Football’s 2018 Opening Day – Lessons Learned from a 6 Hour MCI\nPsychedelic Emergency Response (PER): Reducing Drug-related Harms at Large Music Festivals\nThe Hindu Pilgrimage: A High-Altitude Mass Gathering\nStop the Bleed: Bleeding Control (BCON) Instructor Course\nImpact of Interprofessional Training on Pediatric Mass Casualty Incident Disaster Preparedness\n\nPlease visit the Mass Gathering Medicine Summit 2019 website for more information.
URL:https://globalbiodefense.com/event/mass-gathering-medicine-summit-2019/
LOCATION:SLS Las Vegas\, a Tribute Portfolio Resort\, 2535 S Las Vegas Blvd\, Las Vegas\, NV\, 89109\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/02/96deea70656c19c5e2ac38c4f78c7ddd.jpg
ORGANIZER;CN="American Academy of Event Medicine":MAILTO:info@massgatheringmedicine.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20190429T044226Z
CREATED:20190223T193806Z
LAST-MODIFIED:20190429T044226Z
UID:23754-1552435200-1552607999@globalbiodefense.com
SUMMARY:NIAID Research Career K-Program Development Workshop
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) will host a Research Career “K” Development Workshop 13-14 March 2019 in Rockville\, Maryland. \nThe event is for currently active and new (typically those in year 1 or year 2 of their K award by the end of fiscal year 2018) awardees for the following K programs: \n\nMentored Research Scientist Development Award (K01)\nMentored Clinical Scientist Research Career Development Award (K08)\nNIAID Career Transition Award (K22)\nMentored Patient-Oriented Research Career Development Award (K23)\nMentored Quantitative Research Development Award (K25)\nNIH Pathway to Independence Award (Parent K99/R00)\n\nThe workshop will provide effective ways to transition to research independence (e.g.\, R01 award); the primary goal of the K programs. \nThe workshop will be held on Wednesday\, March 13\, 2019 thru Thursday\, March 14\, 2019 at NIAID\, located at 5601 Fishers Lane in Rockville\, Maryland 20892. \nThe purpose of this workshop is to allow for the exchange of information regarding NIH biomedical research opportunities and professional skills development. It will also provide an opportunity for K awardees to network and interact with their peers and NIAID/NIH staff. Interested K awardees may present their research findings during a poster session. \nThe workshop is free but space may be limited. Please register here.
URL:https://globalbiodefense.com/event/niaid-research-career-k-program-development-workshop/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/niaid-k-researcher-career-development.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190314
DTSTAMP:20190308T222641Z
CREATED:20190304T173047Z
LAST-MODIFIED:20190308T222641Z
UID:24529-1552435200-1552521599@globalbiodefense.com
SUMMARY:CDC Second Wednesday Webinar: Medical Countermeasure Planning
DESCRIPTION:The U.S. Centers for Disease Control and Prevention (CDC) will present the March Second Wednesday Webinar from 1 p.m. to 2 p.m. EDT on Wednesday\, March 13. The presentation will highlight anthrax and pandemic influenza readiness key components in preparation for the next Public Health Emergency Preparedness (PHEP) cooperative agreement performance period. \nRegistration is not required to join this webinar via Adobe Connect. Participants can log onto https://adobeconnect.cdc.gov/r6ooog3mlz5/ to view the webinar. To listen to the audio portion via a phone line\, dial 1-888-455-3007 and enter participant passcode 4330935. \nCEUs will not be offered for this presentation. For more information on the Second Wednesday Webinar series\, contact preparedness@cdc.gov \nBackground: PHEP is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable. \nIn response to the 2009 H1N1 influenza pandemic\, CDC also helped communities through the Public Health Emergency Response grant to increase state and local preparedness and response capacity during the pandemic. The recipients included the 62 PHEP awardees.
URL:https://globalbiodefense.com/event/cdc-second-wednesday-webinar-medical-countermeasure-planning/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/cdc-medical-countermeasure-planning-webinar-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190312T190000
DTEND;TZID=America/Los_Angeles:20190312T200000
DTSTAMP:20190310T002256Z
CREATED:20190210T195745Z
LAST-MODIFIED:20190310T002256Z
UID:21875-1552417200-1552420800@globalbiodefense.com
SUMMARY:Biosafety Concerns of Cell Sorting: Policies\, Procedures\, and PPE
DESCRIPTION:The ChABSA will host a technical seminar by Drs. Kristen Reifel and Brandon Swan on the biosafety concerns involved in cell sorting on March 12\, 2019 in Frederick\, Md. Remote participation is available via webcast. \nDr. Kristen M. Reifel is a Principal Investigator in the Genomics group at the National Biodefense Analysis and Countermeasures Center (NBACC). She is also a member of the International Society for Advancement of Cytometry (ISAC) Biosafety Committee\, and recently selected as an ISAC Shared Resource Laboratory Emerging Leader. \nDr. Brandon K. Swan is a Principal Investigator in the Genomics group at NBACC. He received his PhD in Marine Science from the University of California\, Santa Barbara and was a Postdoctoral Fellow at the Single Cell Genomics Center located at the Bigelow Laboratory for Ocean Sciences\, the first user facility established for single cell genomic sequencing. \nRegistration for the event is required. \nThe Chesapeake Area Biological Safety Association (ChABSA)\, is an incorporated\, non-profit organization that is an affiliate of the American Biological Safety Association (ABSA). ChABSA was established in 1987 by local area members of ABSA with a similar interest in the safety of research using microorganisms and recombinant DNA.
URL:https://globalbiodefense.com/event/biosafety-concerns-of-cell-sorting-policies-procedures-and-ppe/
LOCATION:Hood College Coblentz Hall\, 650 Blazer Trail\, Frederick\, MD\, 21701\, United States
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/biosafety-concerns-cell-sorting.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190312T130000
DTEND;TZID=America/New_York:20190312T140000
DTSTAMP:20190309T183541Z
CREATED:20190215T182040Z
LAST-MODIFIED:20190309T183541Z
UID:24618-1552395600-1552399200@globalbiodefense.com
SUMMARY:Planning Webinar: Tools and Resources for Upcoming National Infant Immunization Week
DESCRIPTION:Join the Centers for Disease Control and Prevention (CDC) for a planning webinar on 12 March 2019 to learn about National Infant Immunization Week planning tools\, digital communication resources\, and how to get involved with CDC activities planned for the week. \nThis year marks the 25th anniversary of National Infant Immunization Week (NIIW). From April 27-May 4\, 2019\, NIIW will highlight the importance of protecting infants from vaccine-preventable diseases and will celebrate the achievements of immunization programs in promoting healthy communities throughout the United States. \nPlease visit the registration website and sign up today.
URL:https://globalbiodefense.com/event/planning-webinar-tools-and-resources-for-upcoming-national-infant-immunization-week/
LOCATION:Webinar
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/national-infant-immunization-week.png
ORGANIZER;CN="Public Health Foundation":MAILTO:info@phf.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190314
DTSTAMP:20220906T195454Z
CREATED:20190208T212321Z
LAST-MODIFIED:20220906T195454Z
UID:23475-1552348800-1552521599@globalbiodefense.com
SUMMARY:Long-Term Health Monitoring following Nuclear & Radiological Emergencies
DESCRIPTION:The National Academies’ Nuclear and Radiation Studies Board (NRSB) will host “Challenges in Initiating and Conducting Long-Term Health Monitoring of Populations following Nuclear and Radiological Emergencies in the United States: A Workshop” on 12-13 March 2019 in Washington\, D.C. \nWorkshop participants will discuss the following topics: \n\nEnvironmental Consequences of Radioactive Material following a Nuclear or Radiological Incident\nThe need to Prepare for Population Monitoring\nRadiation Dose Reconstruction\nBiodosimetry Tools for Long-Term Health Monitoring\nFollow-up of the Atomic Bombing Survivors\nCommunicating Health Monitoring Following the Salisbury Nerve Agent Attack\nThe Chernobyl Registry\nDosimetry During the Radiological Accident in Goiânia\nThe Fukushima Registry\nRadiation Screening/Decontamination\nMedical Management of Radiation Incidents\nLong-Term Strategies for Thyroid Health Monitoring after Nuclear Accidents\nLessons Learned from Setting up Population Monitoring Registries\nThe Las Vegas Mass Shooting\nOperational Considerations for Setting up and Maintaining a Radiation Registry\n\nAttend in-person or via webcast. Please visit the event registration page for more information.
URL:https://globalbiodefense.com/event/long-term-health-monitoring-following-nuclear-radiological-emergencies/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/03/nuclear-radiation-studies-board-12mar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190311T183000
DTEND;TZID=America/New_York:20190311T193000
DTSTAMP:20190308T191823Z
CREATED:20190228T232519Z
LAST-MODIFIED:20190308T191823Z
UID:24286-1552329000-1552332600@globalbiodefense.com
SUMMARY:NEIDL Annual Meeting - National Emerging Infectious Diseases Laboratories
DESCRIPTION:The National Emerging Infectious Diseases Laboratories (NEIDL) of Boston University will hold a public annual meeting on Monday\, March 11\, 2019. \nThe research activities of the NEIDL faculty focus on pathogenesis of emerging viral\, bacterial\, and protozoa parasitic pathogens and continue to be supported by significant external grant funding. \nNEIDL investigators have successfully competed for over $20M in research and support during FY18 year. Funding comes from a variety of competitive sources\, including the National Institutes of Health\, the Department of Defense\, the pharmaceutical industry\, and private foundations\, as well as subcontracts with faculty at collaborating institutions. \nPlease visit Boston University’s NEIDL Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/neidl-annual-meeting/
LOCATION:Hampton Inn and Suites – Boston Crosstown Center\, 811 Massachusetts Ave\, Boston\, MA\, 02118\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/bu-neidl-annual-meeting-bsl4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190310
DTEND;VALUE=DATE:20190316
DTSTAMP:20190308T182335Z
CREATED:20190105T224017Z
LAST-MODIFIED:20190308T182335Z
UID:24596-1552176000-1552694399@globalbiodefense.com
SUMMARY:Molecular Med TRI-CON 2019
DESCRIPTION:The annual Molecular Med TRI-CON 2019 event will be held March 10-15\, 2019 in San Francisco\, California. \nHighlighted topics include: \n\nMolecular diagnostics for infectious disease\nPoint-of-care diagnostics\nSample prep\, assay development and validation\nCompanion diagnostics and clinical biomarkers\nSensors\, wearables and IoT\nNeoantigen-based immunotherapies\nDigital pathology\nPCR and NGS-based molecular diagnostics\nDx reimbursement outlook\nSingle cell analysis\nCirculating cell-free DNA\nMicrobiome-based precision medicine\nCRISPR for precision medicine\nData science\, precision medicine and machine learning\n\nPlease visit Cambridge Healthtech Institute’s Molecular Med TRI-CON 2019 website for more information. \n 
URL:https://globalbiodefense.com/event/molecular-med-tri-con-2019/
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/2019-chi-molecular-med-tri-con.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190308T080000
DTEND;TZID=America/New_York:20190308T170000
DTSTAMP:20190308T185212Z
CREATED:20190206T021327Z
LAST-MODIFIED:20190308T185212Z
UID:22420-1552032000-1552064400@globalbiodefense.com
SUMMARY:FDA Microbiology Devices Panel Advisory Committee: HPV Diagnostics
DESCRIPTION:A public advisory committee meeting of the FDA’s Microbiology Devices Panel be held on March 8\, 2019 in Gaithersburg\, Maryland. \nThe committee will discuss and make recommendations regarding new or alternative approaches to the clinical study design and evaluation of devices detecting Human Papillomavirus (HPV) nucleic acid. \nTopics to be addressed at the meeting include clinical study design and comparator methods. Additionally\, the committee will discuss potential changes to the High Risk HPV device indications for use considering continually evolving cervical cancer screening guidelines. The committee will provide expert feedback regarding the benefits and risks from the adoption of changes in each of the above topics and make recommendations for future High Risk HPV device evaluation strategies that are both scientifically rigorous and least burdensome. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. Written submissions may be made to the contact person on or before March 1\, 2019. Oral presentations from the public will be scheduled on March 8\, 2019\, between approximately 1 p.m. and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present\, the names and addresses of proposed participants\, and an indication of the approximate time requested to make their presentation on or before February 21\, 2019. \nFor further information please contact Aden Asefa\, Center for Devices and Radiological Health\, Aden.Asefa@fda.hhs.gov\, 301-796-0400\, or FDA Advisory Committee Information Line\, 1-800-741-8138.
URL:https://globalbiodefense.com/event/microbiology-devices-panel-advisory-committee-hpv-diagnostics/
LOCATION:Hilton Washington DC North Gaithersburg\, 620 Perry Pkwy\, Gaithersburg\, MD\, 20877\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T192421Z
CREATED:20190224T232313Z
LAST-MODIFIED:20240623T192421Z
UID:24699-1552003200-1552089599@globalbiodefense.com
SUMMARY:Call for Reports: Evidence-Based Practices for Public Health Emergency Preparedness and Response
DESCRIPTION:Committee on Evidence – Based Practices for Public Health Emergency Preparedness and Response \nThe National Academies of Sciences\, Engineering\, and Medicine s soliciting information to help inform the deliberations of a consensus study committee sponsored by the Centers for Disease Control and Prevention. \nThe committee has been charged with conducting a comprehensive review and grading of the evidence for select public health emergency preparedness and response (PHEPR) practices. The committee’s report will provide recommendations on PHEPR practices that public health agencies should or should not adopt based on the evidence and will also identify future research needs to address gaps in evidence-based PHEPR practices. \nThe committee is issuing a call for reports to help enhance its comprehensive review. \nAnyone wishing to submit reports should email the committee at preparedness@nas.edu. Materials should be submitted by Friday\, March 8\, 2019. Please note that any materials or written information shared with the committee will be placed in the committee’s Public Access File (PAF)\, and may be provided to the public upon request.
URL:https://globalbiodefense.com/event/call-for-reports-evidence-based-practices-for-public-health-emergency-preparedness-and-response/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T231311Z
CREATED:20190223T200908Z
LAST-MODIFIED:20240623T231311Z
UID:23755-1552003200-1552089599@globalbiodefense.com
SUMMARY:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance
DESCRIPTION:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance by March 8\, 2019. \nNIAID is refining the five-year strategic framework for antibacterial resistance (AR) research and development\, Antibacterial Resistance Program: Current Status and Future Directions pdf. \nPublished in 2014\, the framework identified the following priorities: \n\nSystems Biology and Antibacterial Resistance: New Directions for Drug Discovery\nHarnessing the Immune System to Combat Bacterial Infections\nDisarm\, But Leave Unharmed: Exploring Anti-Virulence Strategies\nSynthetic Microbiota: An Ecobiological Approach\nLess Is Better: Diagnostics to Guide Use of Narrow-Spectrum Therapeutics\nExploiting Natural Predators: The Specificity of Phage Therapy\nTeaching Old Drugs New Tricks: Extending the Clinical Utility of Antibacterial Drugs\n\nNIAID seeks community feedback to inform an update of the framework. Send your comments identifying: \n\nAdditional research activities needed to help advance the above-listed strategic approaches\nAdditional strategic approaches or technologies that have the potential to transform our understanding of and ability to prevent\, diagnose\, or treat resistant bacterial infections\n\nTo submit a response\, send a PDF or MS Word document of 500 words or less to NIAIDAntibioticResistanceRFI2019@niaid.nih.gov. The deadline to reply is March 8\, 2019. Take care to avoid sharing any proprietary\, classified\, confidential\, trade secret\, or sensitive information in your response.
URL:https://globalbiodefense.com/event/niaid-research-framework-amr-deadline-2019/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190305
DTEND;VALUE=DATE:20190307
DTSTAMP:20190429T044246Z
CREATED:20190224T202524Z
LAST-MODIFIED:20190429T044246Z
UID:23766-1551744000-1551916799@globalbiodefense.com
SUMMARY:Vaccine Strategies for Endemic Fungal Pathogens
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) will host a Vaccine Strategies for Endemic Fungal Pathogens meeting on 5-6 March 2019 to discuss the scope of endemic fungal disease\, learn about the latest discoveries\, and determine actionable steps to advance fungal vaccines. \nThis meeting will take place at the NIAID Conference Center in Rockville\, Maryland and also be webcast. Please indicate when registering whether you will be attending in person or via webcast. Editor’s note: This event registration is now closed (1 Mar). If you need to register for the webcast\, please contact Christina McCormick\, christina.mccormick@nih.gov. \nHighlighted agenda topics include: \n\nDefending against the Endemic Systemic Mycoses: Advances\, Challenges and Opportunities\nDesigning and Building the Next Generation of Vaccine Adjuvants\nHost Defense Against Dimorphic Fungal Pathogens: Critical Lessons from Inherited\nand Acquired Human Immunodeficiencies\nVaccines to Prevent Coccidioidomycosis: 60 Years and Counting\nChallenges in a Coccidiodal Vaccine Development\nUpdate in Histoplasmosis and Blastomycosis Epidemiology\nUpdate on Cross-Kingdom Vaccine: Scientific and Developmental Challenges\nNIAID Support for Vaccine Development\nImmunity to Valley Fever: Of Mice and Men\nAdjuvants for Fungal Vaccines\nEndemic Mycoses in Asia\nEpidemiology of Coccidioidomycosis in the United States: With New Insights from the Southern California Experience\nSpeciation of Coccidioides and Potential Biomarkers\n\nPlease visit the Vaccine Strategies for Endemic Fungal Pathogens website for more information.
URL:https://globalbiodefense.com/event/vaccine-strategies-for-endemic-fungal-pathogens/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190305
DTEND;VALUE=DATE:20190307
DTSTAMP:20190308T001150Z
CREATED:20190211T020702Z
LAST-MODIFIED:20190308T001150Z
UID:19611-1551744000-1551916799@globalbiodefense.com
SUMMARY:National Health Symposium 2019
DESCRIPTION:The Johns Hopkins University Applied Physics Laboratory will host the inaugural National Health Symposium on March 5-6\, 2019 at the Kossiakoff Center in Laurel\, MD. \nThe symposium will focus on the translation of advances in research and development to the delivery of care in all settings.  Bringing together leaders in research and operations\, this program will explore the latest breakthroughs and identify practical approaches to overcoming barriers to engineer an envisioned future for health. \nThe Johns Hopkins University Applied Physics Laboratory in Laurel\, Maryland\, will host “Bridging the Health Divide: From Research to Operations\,” an inaugural National Health Symposium\, held in partnership with the National Defense Industrial Association (NDIA) on March 5–6\, 2019\, at the Kossiakoff Center on APL’s main campus. \nThe symposium will focus on the translation of advances in research and development to the delivery of care in all settings. Leaders in research and operations will explore the latest breakthroughs and identify practical approaches to overcoming barriers to engineer an envisioned future for health. \nThe goal is to bring together leaders across government\, industry and academia to explore more effective ways to move research discoveries into operational practice. \nThe symposium features several distinguished speakers including Vice Admiral Raquel C. Bono\, director of the Defense Health Agency; Admiral Brett Giroir\, assistant secretary for health for the U.S. Department of Health and Human Services; and Dr. Antony Rosen\, vice dean for research\, professor of medicine at the Johns Hopkins School of Medicine. \n“Ensuring we have a process by which new breakthroughs and better engineered health solutions are adopted is critical\,” said National Health Mission Area Executive Sezin Palmer of Johns Hopkins APL. “We’re excited to share this opportunity with NDIA to discuss how we can tackle these challenges by working collaboratively across government\, industry and academia.” \nPanel sessions\, lightning talks and exhibits will focus on three impact areas: \n\nRealizing the Promise of Health Sciences: highlighting the potential of recent scientific breakthroughs; identifying the obstacles to realizing these breakthroughs; and defining a research agenda that will achieve the impact despite the obstacles.\nEngineering the Future of Medicine: unfolding an engineered vision for the future of health; naming the obstacles to implementing well-engineered solutions; and creating a technology development and implementation agenda to realize the future.\nDelivering Health Everywhere: imagining a future where health can be protected in all environments; recognizing the unique challenges of delivering care to the home\, in combat\, and in the midst of a natural or man-made disaster; and highlighting innovations that have transformative potential in delivering high-quality care everywhere.\n\nPlease visit National Health Symposium website for more information.
URL:https://globalbiodefense.com/event/jhu-apl-national-health-symposium-2019/
LOCATION:Johns Hopkins Applied Physics Laboratory\, 11100 Johns Hopkins Road\, Laurel\, MD\, 20723\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190304
DTEND;VALUE=DATE:20190308
DTSTAMP:20190429T044259Z
CREATED:20190210T182051Z
LAST-MODIFIED:20190429T044259Z
UID:19288-1551657600-1552003199@globalbiodefense.com
SUMMARY:CROI 2019 - Conference on Retroviruses and Opportunistic Infection
DESCRIPTION:The 2019 Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 4 to March 7\, 2019 in Seattle\, Washington. \nThis well-respected conference brings together top basic\, translational\, and clinical researchers from around the world to share the latest studies\, important developments\, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. \nAn extensive speaker agenda and poster sessions will cover topics in scientific areas of: \n\nPathogenesis: Human Studies and Animal Models\nHIV-Associated Tumor Viruses\nHost Immune Responses to Infection\, Vaccines\, and Immunotherapy\nHIV Reservoirs\, Latency\, and All Curative Strategies Including Therapeutic Vaccines\nand Gene Therapy\nNeuropathogenesis and Neurologic Complications\nClinical Pharmacology\nAntiretroviral Therapy: Pre-Clinical Data\, Randomized Trials\, Efficacy and Effectiveness Studies\nHIV Drug Resistance\nHIV Diagnostics\nHepatitis Viruses and Liver Complications\nAIDS-Related Malignancies\nCardiovascular Complications of HIV Infection and Antiretroviral Therapy\nTuberculosis and Other Opportunistic Infections\nMaternal and Fetal HIV\nEpidemiology\nPrevention Interventions\nContraception\, Sexually Transmitted Infections\, and Reproductive Health\nImplementation and Scale-Up of Treatment and Care\nPopulation and Cost Modeling\n\nPlease visit the Conference on Retroviruses and Opportunistic Infections (CROI) website for more information.
URL:https://globalbiodefense.com/event/croi-2019-conference-on-retroviruses-and-opportunistic-infection/
LOCATION:Washington State Convention Center\, 800 Convention Pl\, Seattle\, WA\, 98101\, United States
CATEGORIES:Conference,Continuing Education
ORGANIZER;CN="International Antiviral Society-USA":MAILTO:info@iasusa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190303
DTEND;VALUE=DATE:20190309
DTSTAMP:20190304T184021Z
CREATED:20190215T205926Z
LAST-MODIFIED:20190304T184021Z
UID:23597-1551571200-1552089599@globalbiodefense.com
SUMMARY:Detection\, Countermeasures and Prevention of Chemical and Biological Threats
DESCRIPTION:The 2019 Detection\, Countermeasures and Prevention of Chemical and Biological Threats Gordon Research Conference will be held March 3-8\, 2019 in Ventura\, California. \nMajor topic areas will include novel imaging techniques that follow host response to chemical and biological insults\, novel approaches to countering antimicrobial resistance\, new detection technologies and the integration of understanding the problems and advances in agriculture bioterrorism. \nPresenters and moderators include: \n\nCatharine Bosio – Rocky Mountain Laboratories\nCrystal Jaing – Lawrence Livermore National Laboratory\nDavid Segal – University of California\, Davis\nPeter Hotchkiss – Sandia National Laboratories\nIan Gut – National Biodefense Analysis and Countermeasures Center\nAmanda Burkhardt – University of California\, Irvine\nSina Bavari – U.S. Army Medical Research Institute of Infectious Diseases\nMohammed Athar – University of Alabama at Birmingham\nJuergen Richt – Kansas State University\nCatherine Branda – Sandia National Laboratories\nLivia Veress – University of Colorado Denver\nKevin Yehl – Massachusetts Institute of Technology\nMichael Bassik – Stanford University\nPeter Nguyen – Wyss Institute for Biologically Inspired Engineering\nPaula Vanninen – University of Helsinki\nRichard Ozanich – Pacific Northwest National Laboratory\nBarbara Drolet – USDA Agricultural Research Service\nCharles Thompson – University of Montana\nRushika Perera – Colorado State University\nRaga Krishnakumar – Sandia National Laboratories\nSven-Eric Jordt – Duke University\nJoseph Fernandez – The Ohio State University\nCassandra Quave – Emory University\n\nHighlighted topics include: \n\nRift Valley Fever: Development of Mitigation Strategies in Target Animals\nNovel Adjuvant Systems Elicit Protective Cellular and Humoral Immune Responses Against the Bioterrorism Agent Coxiella burnetti in Polyvalent Vaccine Formulations\nInsights into the Phenotypic and Virulence Differences Observed in Two Lineages of Burkholderia pseudomallei 1026b\nIFN-Gamma Induced Mitochondrial Reprogramming to Control F. tularensis\nSensAlert: Transforming Wearable Sensor Data for Early Warning\, Health Surveillance\nExploitation of the Phagolysosome by Bacillus anthracis in Human Cells\nProtein-Tyrosine Phosphatases: Host Targets to Counter Bacterial Infection\nCountermeasures for Pulmonary and Dermatological Chemical Threats\nMolecular Imaging of High Consequence Viral Infections\nInfectious Diseases Imaging: Counter Bioterrorism Tools for the 21st Century\nThe Role of Cooperative Threat Reduction in Chem/Bio Terrorism Defense and Synergies with R&D\nTargeted NGS for Detection of Anti-Microbial Resistance\nA Long-Lasting Catalytic Organophosphate Scavenger for Pre-Treatment of Nerve Agent Exposure\nDissecting Complex Molecular Pathogenesis of Warfare Vesicants Arsenicals\nMicroneedle Diagnostics and Transdermal Fluid Sampling Strategies for Real-Time Health and Exposure Monitoring\nMetabolite Biomarkers of Emerging Infectious Diseases\nTransboundary Arboviral Threats to U.S. Agriculture\nField Technical Exercise FOCUS: A Preliminary Evaluation of the Integrated Sensing System Test of the TOXI-Triage Concepts of Comprehensive Data Capture Across the Casualty Journey\nIn Vivo Delivery of CRISPR Medical Countermeasures and Stem-Cell-Based Countermeasures\nGenetic and Epigenetic Engineering Opportunities and Challenges for Biodefense\nSynthetic mRNA Based Expression of Activatable RNAses as Tools for Treating RNA Virus Infections\nSendai Virus Delivery of CRISPR/Cas Machineries for Highly Efficient Gene Editing in Hematopoietic Stem Cells\, Myeloid Cells and Dendritic Cells\n\nPlease visit the 2019 Detection\, Countermeasures and Prevention of Chemical and Biological Threats website for more information.
URL:https://globalbiodefense.com/event/detection-countermeasures-and-prevention-of-chemical-and-biological-threats/
LOCATION:Ventura Beach Marriott\, 2055 Harbor Boulevard\, 2055 E Harbor Blvd\,\, CA\, 93001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190227
DTEND;VALUE=DATE:20190303
DTSTAMP:20181225T201437Z
CREATED:20181225T201345Z
LAST-MODIFIED:20181225T201437Z
UID:20800-1551225600-1551571199@globalbiodefense.com
SUMMARY:Advances in Genome Biology and Technology (AGBT)
DESCRIPTION:The Advances in Genome Biology and Technology (AGBT) General Meeting will be held Feb 27 – Mar 2\, 2019 on Marco Island\, Florida. \nAGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies\, experimental and analytical approaches for genomic studies\, and their myriad applications. \nHighlighted presentation topics include: \n\nHeterochromatin and genome evolution\nHistorical pathogen population genomics using selective genome enrichment to identify non-classical drug resistance mechanisms\nIdentity inference of genomic data using long-range familial searches\nTranscript expression-aware annotation increases power for rare variant discovery in Mendelian and complex disease\nCharacterization of splicing diversity and gene fusions through Nanopore sequencing\nSingle cell-RNA-seq identifies a unique microglia type associate with Alzheimer’s disease\nSpatial mapping of host-microbiome interactions in the gut\nAssembly of long error-prone reads using repeat graphs\nIsoform sequencing in tissues\, cell types and thousands of cells\nFrom here to Mars: How the Twins Study and the year-long ISS mission have moved us closer to the red planet\nCell atlases as road maps to human disease\nA rigorous study of the need for Sanger confirmation in clinical genetic testing\n\nPlease visit the AGBT 2019 website for more information.
URL:https://globalbiodefense.com/event/advances-in-genome-biology-and-technology-agbt/
LOCATION:JW Marriott Marco Island Beach Resort\, 400 S Collier Blvd\, Marco Island\, FL\, 34145\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/12/agbt-2019-genome-biology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190221
DTSTAMP:20190429T044315Z
CREATED:20190121T182518Z
LAST-MODIFIED:20190429T044315Z
UID:20647-1550620800-1550707199@globalbiodefense.com
SUMMARY:Mass Drug Administration and Antimicrobial Resistance
DESCRIPTION:The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center\, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London\, UK and by live stream. \nMass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium will bring together academics from a range of relevant disciplines to discuss the state of evidence\, and draw out a future integrated research agenda that addresses potential hurdles with this approach\, including concerns about antimicrobial resistance. \nPlease visit the LSHTM Antimicrobial Resistance Centre’s website for more information.
URL:https://globalbiodefense.com/event/mass-drug-administration-antimicrobial-resistance/
LOCATION:John Snow Lecture Theatre – LSHTM\, Keppel Street\, London\, WC1E 7HT\, United Kingdom
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/mass-drug-administration-amr-lshtm.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190205T103000
DTEND;TZID=America/New_York:20190205T153000
DTSTAMP:20190125T022341Z
CREATED:20190115T023245Z
LAST-MODIFIED:20190125T022341Z
UID:20475-1549362600-1549380600@globalbiodefense.com
SUMMARY:Fighting the Next War: Defense Against Biological Weapons
DESCRIPTION:The Blue Ribbon Study Panel on Biodefense will host an in-depth discussion on the role of the U.S. Defense Department in biodefense on February 5th\, 2019 in Washington\, DC. \nParticipants will share their experiences regarding the current threat environment\, research and development programs\, and the Department’s biodefense policies. \nRSVP by January 30\, 2019. Attendance is free\, but registration is required. This event will also be webcast.
URL:https://globalbiodefense.com/event/fighting-the-next-war-defense-against-biological-weapons/
LOCATION:Council on Foreign Relations\, 1777 F Street\, NW\, Washington\, DC\, 20006\, United States
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/blue-ribbon-study-panel-biodefense.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190204
DTEND;VALUE=DATE:20190205
DTSTAMP:20190121T195504Z
CREATED:20190121T195112Z
LAST-MODIFIED:20190121T195504Z
UID:21908-1549238400-1549324799@globalbiodefense.com
SUMMARY:National Toxicology Program Peer-Review Meeting on Effects of Sarin Exposure
DESCRIPTION:The National Toxicology Program will host a public webinar on 4 Feb 2019 to discuss the draft findings of a systematic review to evaluate the evidence for long-term neurological effects in humans and animals following acute exposure to sarin. \nSarin is a highly toxic organophosphorus nerve agent that was developed for chemical warfare during World War II and continues to be used as a weapon. Long-term neurological effects of acute exposure to sarin are not well characterized. \nRegistration is required for attendance and to present oral comments. The webcast is open to the public. \nLearn more: Long-Term Effects Following Acute Exposure to Sarin Nerve Agent
URL:https://globalbiodefense.com/event/peer-review-meeting-on-long-term-effects-of-nerve-agent-exposure/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/sarin-nerve-agent.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190129T123000
DTEND;TZID=America/New_York:20190129T140000
DTSTAMP:20190125T045928Z
CREATED:20190125T045201Z
LAST-MODIFIED:20190125T045928Z
UID:22193-1548765000-1548770400@globalbiodefense.com
SUMMARY:Fighting Ebola in DRC: New Tools and New Challenges
DESCRIPTION:Join Doctors Without Borders for a live webcast panel discussion on January 29 from 12:30 PM – 2:00 PM EST on efforts to contain the current Ebola epidemic in Democratic Republic of Congo (DRC). \nMSF teams are responding to the second largest Ebola outbreak ever recorded\, trying to halt the spread of this highly infectious\, deadly disease. The epicenter of the outbreak is in a conflict area in North Kivu province\, making a rapid response difficult. \nPanelists will explore the evolving medical approaches to fighting the Ebola virus\, the initiation of a randomized controlled trial testing treatment options\, and the unique ethical and logistical considerations this outbreak presents. \nAt the time of the event\, tune in to the webcast here. \n\nKarin Huster\, MSF Project Coordinator\, earned a BS in Nursing from the University of Washington in 2005 and her Master in Public Health degree from UW’s department of global health in 2013. After nine years working as a nurse in the intensive care unit of a large trauma center\, Karin now focuses on responding to humanitarian emergencies\, either in a clinical capacity\, as a field epidemiologist\, or field coordinator. She has also worked as an advisor to the emergency response branch of USAID. Most recently\, Karin returned from DRC where she helped launch MSF’s response to the Ebola outbreak and later returned to manage an MSF transit center for people with suspected cases of Ebola. In 2014\, she worked as part of the response in each of the three West African countries affected by the largest Ebola outbreak in history. She has also worked in Iraq\, Bangladesh\, Nigeria\, Haiti\, and Lebanon. \nDr. Brian D’Cruz\, MSF Physician\, has worked with MSF since 2011\, and recently returned from MSF’s Ebola intervention in Beni\, DRC. In 2014–2015\, Brian participated in MSF’s response to the West Africa Ebola outbreak in Guinea. He has also worked at MSF projects in Burundi\, Central African Republic\, Syria\, and Chad. \nDr. Tomas Jensen\, MSF Tropical Medicine Advisor\, is an infectious diseases physician currently based in New York as an advisor on tropical medicine and epidemics for MSF. He started working with MSF in 2006 as a field doctor and has worked in several countries including South Sudan\, Ethiopia\, Zimbabwe\, South Africa\, and Zambia. After finishing medical school in Denmark\, Tomas completed infectious diseases specialist training in Australia and a master’s degree in epidemiology with the London School of Hygiene and Tropical Medicine. \nThe discussion will be moderated by Sandra Murillo\, MSF-USA Media Relations Director.
URL:https://globalbiodefense.com/event/msf-fighting-ebola-in-drc-new-tools-new-challenges/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/01/ebola-msf-doctors-without-borders.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190129
DTEND;VALUE=DATE:20190201
DTSTAMP:20190304T044504Z
CREATED:20181008T172632Z
LAST-MODIFIED:20190304T044504Z
UID:17192-1548720000-1548979199@globalbiodefense.com
SUMMARY:2019 ASM Biothreats
DESCRIPTION:The American Society for Microbiology’s 2019 ASM Biothreats meeting will be held January 29–31\, 2019\, in Arlington\, Virginia. \nThis leading annual event\, formerly known as the ASM Biodefense and Emerging Diseases Research Meeting\, is a forum for the discussion of new data from the research of microbiological sciences related to biodefense and bioterrorism\, the latest information on preventative modalities\, therapeutics\, and clinical diagnoses related to high consequence pathogens\, and the most recent trends in the management and planning of biothreat programs. \nA highlight of this meeting is Biothreats Peer-to-Peer\, a half-day pre-meeting symposium providing students and early career professionals the unique opportunity to make an oral presentation to a group of their peers. Speakers from the full Biothreats program have been invited to discuss their careers and job opportunities in the field. \nRegistration opens the second week of November. Please visit the ASM Biothreats website for more information. \nGlobal Biodefense in an official media partner of the 2019 ASM Biothreats meeting.
URL:https://globalbiodefense.com/event/2019-asm-biothreats/
LOCATION:Hyatt Regency Crystal City\, 2799 Jefferson Davis Highway\, Arlington\, VA\, 22202\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/10/asm-biothreats-register-today-2019.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190202
DTSTAMP:20190125T021908Z
CREATED:20190125T021908Z
LAST-MODIFIED:20190125T021908Z
UID:21876-1548633600-1549065599@globalbiodefense.com
SUMMARY:BSL-3 Laboratory Training
DESCRIPTION:UC Irvine will host an integrated course for high containment laboratory safety practices 28 Jan – 1 Feb 2019 in Irvine\, CA. \nBSL-3 Laboratory Training is a five-day intensive training for laboratory staff\, managers\, biosafety professionals\, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: \n\nReview of biosafety principles and levels\nRisk assessment and management\nWaste management\nLaboratory management\nSafety procedures\nEmergency management\nBiosafety cabinet practices and procedures\nSmall and large spill decontamination\nDonning and doffing PPE\nLaboratory operations and preventative maintenance\nData and material management\nInventory and records management\nBiosecurity\n\nContact course coordinator for more information: Tran Phan\, 949-824-9536\, bl3train@uci.edu
URL:https://globalbiodefense.com/event/bsl-3-laboratory-training/
LOCATION:UC Irvine BSL-3 Training Center\, 4600 Health Sciences Rd.\, Irvine\, CA\, 92697\, United States
CATEGORIES:Continuing Education,Training
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/bsl-3-uc-irvine-training.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190129
DTSTAMP:20190125T024559Z
CREATED:20190112T234229Z
LAST-MODIFIED:20190125T024559Z
UID:21914-1548633600-1548719999@globalbiodefense.com
SUMMARY:NAS Public Meeting on Safeguarding the Bioeconomy
DESCRIPTION:The public is invited to an open session of committee members convened by the National Academies of Sciences\, Engineering\, and Medicine to review the U.S. bioeconomy\, assess opportunities\, and consider strategies to protect its intangible assets (such as data and intellectual property)\, while sustaining innovation. \n“Finding Strategies for Understanding\, Evaluating\, and Protecting the Bioeconomy while Sustaining Innovation and Growth” will be held on January 28\, 2019 in Washington\, DC and via Webcast. \nTo learn more about this study\, visit their website. \nThe study is sponsored by the Office of the Director of National Intelligence.
URL:https://globalbiodefense.com/event/nas-public-meeting-on-safeguarding-the-bioeconomy/
LOCATION:National Academy of Sciences\, 2101 Constitution Avenue Northwest\, Washington\, DC\, 20418\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/safeguarding-the-bioeconomy-nas.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190129
DTSTAMP:20190125T013842Z
CREATED:20190125T013614Z
LAST-MODIFIED:20190125T013842Z
UID:22171-1548633600-1548719999@globalbiodefense.com
SUMMARY:Comments Due: Code of Conduct for Timely Sharing of Pathogen Genetic Sequence Data During Outbreak
DESCRIPTION:A key concern in recent outbreaks has been variable timelines between the start of an outbreak and the public availability of the first and subsequent genetic sequences. \nThe World Health Organization (WHO)\, upon consultation with many stakeholders and institutions working in the pathogen sequencing arena\, is proposing elements of a code of conduct for genetic sequencing data sharing in infectious disease outbreaks. \nThrough this code of conduct WHO seeks to enable rapid international sharing of sequence data\, allowing public health authorities\, product developers and researchers to collaborate more effectively from a position of mutual trust with respect for submitters’ rights to the information they provide. \nThe draft document is available for public comment until close of business on 28 January 2019. Comments may be submitted by individuals or organizations\, and will be considered for incorporation in WHO’s final Code of Conduct.
URL:https://globalbiodefense.com/event/comments-due-code-of-conduct-for-timely-sharing-of-pathogen-genetic-sequence-data-during-outbreak/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/genomic-sequencing-data-sharing-code-of-conduct.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190124
DTEND;VALUE=DATE:20190125
DTSTAMP:20181224T220046Z
CREATED:20181109T052912Z
LAST-MODIFIED:20181224T220046Z
UID:18502-1548288000-1548374399@globalbiodefense.com
SUMMARY:NICBR Winter Symposium on Novel Therapeutics
DESCRIPTION:The National Interagency Confederation for Biological Research (NICBR) will host a symposium on novel therapeutics for infectious diseases\, cancer and autoimmunity on January 24\, 2019 in Frederick\, Maryland. \nNICBR is a consortium of eight agencies working in synergy to achieve a healthier and more secure nation. It serves as a framework for facilitating and encouraging interaction among the NICBR member organizations where there are areas of mutual interest. \nThe eight members include elements of the Department of Defense\, Health and Human Services\, Agriculture\, and Homeland Security: \n\nNational Cancer Institute at Frederick\nNational Institute of Allergy and Infectious Diseases\nUS Army Medical Research and Materiel Command\nUS Department of Agriculture\, Agricultural Research Service\nNational Biodefense Analysis and Countermeasures Centers\nCenters for Disease Control and Prevention\nNaval Medical Research Center\nUS Food and Drug Administration\n\nCraig Thomas\, PhD\, NCATS will provide the keynote presentation on “Accelerating Translation: Strategies for Rapid Probe Development\, Drug Combination Discovery and Precision Medicine.” \nIf you are a researcher in the Frederick community working in these areas and would like to give an oral presentation\, please provide a short abstract by Jan. 5\, 2019. It is anticipated that the program will consist of selected oral presentations from the NICBR member agencies. \nRegistration is required. There is no fee for this event.
URL:https://globalbiodefense.com/event/nicbr-winter-symposium-novel-therapeutics/
LOCATION:NCI at Frederick Conference Center\, 549 Sultan St.\, Fort Detrick\, MD\, 21702\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/11/nicbr-frederick.png
ORGANIZER;CN="National Interagency Confederation for Biological Research (NICBR)":MAILTO:usarmy.detrick.medcom-usamrmc.other.nicbr-support@mail.mil
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190115
DTEND;VALUE=DATE:20190117
DTSTAMP:20181224T220022Z
CREATED:20181224T174544Z
LAST-MODIFIED:20181224T220022Z
UID:19294-1547510400-1547683199@globalbiodefense.com
SUMMARY:Vector Control Workshop for Hurricane-Impacted Areas: Montgomery
DESCRIPTION:Two workshops will be hosted in January 2019 to help increase the capacity of local vector control programs in areas affected by Hurricanes Harvey\, Irma\, and Marie to respond to the increased threat of vector-borne diseases following these natural disasters. \nThe Vector Surveillance and Control Workshops will provide the same hands-on training\, tailored instruction\, and practical capacity-building activities targeted to vector control programs in hurricane-affected regions. \nLocal vector control programs in Alabama\, Florida\, Georgia\, Louisiana\, Mississippi\, North Carolina\, South Carolina\, and Texas are invited to attend one of the workshops. \nJanuary 8-9 in Charleston\, SC\nJanuary 15-16 in Montgomery\, AL \nThis training is organized by the National Association of County and City Health Officials (NACCHO)\, in partnership with the American Mosquito Control Association (AMCA) and the CDC Academic Centers for Excellence in Vector-Borne Disease. \nParticipation is capped at 50 attendees per workshop\, and registration is free.
URL:https://globalbiodefense.com/event/vector-control-workshop-for-hurricane-impacted-areas-montgomery/
LOCATION:Embassy Suites by Hilton Montgomery Hotel and Conference Center\, 300 Tallapoosa St\, Montgomery\, AL\, 36104\, United States
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2016/04/vector-borne-diseases.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190105T080000
DTEND;TZID=America/Los_Angeles:20190105T173000
DTSTAMP:20181226T220509Z
CREATED:20181214T001809Z
LAST-MODIFIED:20181226T220509Z
UID:19583-1546675200-1546709400@globalbiodefense.com
SUMMARY:Innovations in Regulatory Science Summit
DESCRIPTION:The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) will host the inaugural Innovations in Regulatory Science Summit on January 5\, 2019 in San Francisco\, CA. \nThe event is a gathering of leaders from academia\, industry and regulatory agencies to discuss the role of regulatory science in medical product development. This event will comprise primarily of panel discussions and short research talks by CERSI investigators on ongoing collaborative research projects with FDA investigators. \nHighlighted topic areas include: \n\nAdvancing Discovery to First-In-Human Clinical Trials for New Medical Products\nOverview of OneSource\nDefining the Strength of Evidence in Therapeutic Development\nBioequivalence and Excipients in Drug Products\nChemoinformatic Tools for Generic Drugs\nAcademia\, Government and Industry in Regulatory Science: Cross-Sector Collaboration and Avoiding Conflicts of Interest\nPatient Preferences in Upper Limb Prostheses\nPatient Reported Outcomes for Minimally Invasive Glaucoma Surgery\nReal-World Evidence\, Artificial Intelligence and Novel Medical Devices\nThe Accelerated Digital Clinical Ecosystem\nIntracranial Closed-Loop Stimulation to Impact Depression\nAccelerating Clinical Trials in the Development and Approval of Innovative Medical Products\n\nMore information is available at http://regscisummit.ucsfstanfordcersi.org/
URL:https://globalbiodefense.com/event/190105-innovations-in-regulatory-science-summit/
LOCATION:Mission Bay Conference Center\, 1675 Owens Street\, San Francisco\, CA\, 94158\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/ucsf-stanford-cersi-science-innovations.jpg
ORGANIZER;CN="UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI)":MAILTO:info@ucsfstanfordcersi.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181214
DTEND;VALUE=DATE:20181215
DTSTAMP:20181224T223152Z
CREATED:20181201T173734Z
LAST-MODIFIED:20181224T223152Z
UID:19521-1544745600-1544831999@globalbiodefense.com
SUMMARY:DARPA Panacea Program - Accessing the Dark Proteome
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. \nThe event will be held on December 14\, 2018 from 10:00 AM to 2:00 PM EST at the Executive Conference Center (ECC; 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA 22203). Advance registration is required. \nPanacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction\, synthesis\, and validation of pharmacological interventions. \nNew drug development for the Panacea program will be focused towards solving two critical problems facing DoD personnel: alleviating pain/inflammation without unwanted side effects and positively mitigating metabolic stress. \nDARPA seeks to bridge the gaps between the chemical space required to identify and produce novel pharmacological interventions and the complex biological space whose functions must be quantified in order to predict and validate the benefits of those interventions for these two desired indications. \nThe success of the Panacea program will represent a paradigm shift in the new drug discovery process and provide new technology that enables more rapid\, safe and effective therapeutic drug development for military and civilian health. \nSpecifically excluded from this effort is research that primarily results in evolutionary improvements to the existing state of practice\, that requires genetic manipulation of the intended recipient\, or that relies on discovering novel pharmacodynamic space for known therapeutics to identify additional indications. \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xP6hD. Please address administrative questions to DARPA-SN-19-12@darpa.mil\, and refer to the Panacea Proposers Day (DARPA-SN-19-12) in all correspondence.
URL:https://globalbiodefense.com/event/darpa-panacea-program-accessing-the-dark-proteome/
LOCATION:Strategic Analysis Executive Conference Center\, 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/darpa-panacea-baa.jpg
END:VEVENT
END:VCALENDAR